The effect of preapplication of corticosteroids on skin irritation and performance of the GlucoWatch G2® Biographer

Diabetes Technology and Therapeutics

Volumn 6, Issue 3, 2004, Pages 357-367

  Tamada, Janet A ^a   Davis, Tara L ^a   Leptien, Amy D ^a   Lee, Jonathan ^a   Wang, Betty ^a   Lopatin, Margarita ^a   Wei, Charles ^a   Wilson, Don ^a   Comyns, Kathleen ^a   Eastman, Richard C ^a  

^a Cygnus Therapeutic Systems   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CORTIZONE; CORTIZONE 10 QUICK SHOT; DESONIDE; FLUOCINONIDE; HYDROCORTISONE; HYDROCORTISONE ACETATE; TRIAMCINOLONE; TRIAMCINOLONE ACETONIDE;

ADULT; AEROSOL; AGED; ARTICLE; BLOOD GLUCOSE MONITORING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DEVICE; DIABETES MELLITUS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; IONTOPHORESIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN IRRITATION;

ADRENAL CORTEX HORMONES; BLOOD GLUCOSE; EDEMA; ERYTHEMA; HUMANS; MONITORING, AMBULATORY; SKIN DISEASES;

EID: 3042637599     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/152091504774198052     Document Type: Article

References (17)

1. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-986.
2. UK Prospective Diabetes Study (UKPDS) Group: Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-853.
3. Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, Kojima Y, Furuyoshi N, Shichiri M: Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 1995;28:103-117.
4. Tamada JA, Garg SK, Jovanovic L, Fermi S, Potts RO, the Cygnus Research Team: Non-invasive glucose monitoring: comprehensive clinical results. JAMA 1999;282:1839-1844.
5. Tierney MJ, Tamada JA, Potts RO, Eastman RC, Pitzer K, Ackerman NR, Fermi SJ: The GlucoWatch Biographer: a frequent, automatic and non-invasive glucose monitor. Ann Med 2000;32:632-641.
6. Garg SK, Potts RO, Ackerman NR, Fermi SJ, Tamada JA, Chase HP: Correlation of fingerstick blood glucose measurements with GlucoWatch Biographer glucose results in young subjects with type 1 diabetes. Diabetes Care 1999;22:1708-1714.
7. Glikfeld P, Hinz RS, Guy RH: Noninvasive sampling of biological fluids by iontophoresis. Pharm Res 1989;6:988-990.
8. Rao G, Glikfeld P, Guy RH: Reverse iontophoresis: development of a noninvasive approach for glucose monitoring. Pharm Res 1993;10:1751-1755.
9. Tamada JA, Bohannon NJV, Potts RO: Measurement of glucose in diabetic subjects using noninvasive transdermal extraction. Nat Med 1995;1:1198-1201.
10. Riviere JE, Heit MC: Electrically-assisted transdermal delivery. Pharm Res 1997;14:687-697.
11. Van der Geest R, Elshove DAR, Danhof M, Larrijsen APM, Bodde HE: Non-invasive assessment of skin barrier integrity and skin irritation following ion-tophoretic current application in humans. J Control Release 1996:41:205-213.
12. Singh J, Gross M, Sage B, Davis HT, Maibach HI: Regional variations in skin barrier function and cutaneous irritation due to iontophoresis in human subjects. Food Chem Toxicol 2001;39:1079-1086.
13. Singh J, Gross M, Sage B., Davis H, Maibach HI: Effect of saline iontophoresis on skin barrier function and cutaneous irritation in four ethnic groups. Food Chem Toxicol 2000;38:717-726.
14. Cormier M, Chao ST, Gupta SK, Haak R: Effect of transdermal iontophoresis codelivery of hydrocortisone on metoclopramide pharmacokinetics and skin-induced reactions in human subjects. J Pharm Sci 1999;88:1030-1034.
15. National Psoriasis Foundation: Steroids. Portland, OR: National Psoriasis Foundation, 1998:6-7.
16. Draize JH, Woodard G, Calvery HD: Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J Pharmacol Exp Ther 1944:83:377-390.
17. Clarke WL, Cox DC, Conder-Frederick LA, Carter W, Pohl SL: Evaluating clinical accuracy of systems for self-monitoring of blood glucose. Diabetes Care 1987;10:622-628.